GOLDBY STEVEN D

CIK 00012166265 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001216626

Recent Transactions

50 trades

Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2019-05-23−4,240→ 0 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2019-05-23−4,240→ 0 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2019-05-23$9.35/sh+4,240→ 73,137 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2019-05-23+4,240→ 73,137 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Nonstatutory Stock Option (Right to Buy)
2019-02-28−5,000→ 5,000 total
Tax Payment
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2019-02-28$12.84/sh−2,593→ 68,897 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2019-02-28$6.66/sh+5,000→ 71,490 total
Purchase
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2019-01-08$11.24/sh+20,000→ 66,490 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Right to Buy Restricted Stock Unit (RSU)
2018-05-30+4,240→ 4,240 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2018-05-23−4,286→ 0 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2018-05-23$13.65/sh+4,286→ 46,490 total
Tax Payment
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2018-02-23$13.30/sh−2,169→ 42,204 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2018-02-23$5.77/sh+5,000→ 44,373 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Nonstatutory Stock Option (Right to Buy)
2018-02-23−5,000→ 5,000 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Right to Buy Restricted Stock Unit (RSU)
2017-06-01+4,286→ 4,286 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2017-05-25−5,282→ 0 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2017-05-25$13.50/sh+5,282→ 39,373 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2017-05-23$5.63/sh+5,000→ 36,191 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Nonstatutory Stock Option (Right to Buy)
2017-05-23−5,000→ 10,000 total
Tax Payment
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2017-05-23$13.40/sh−2,100→ 34,091 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2016-05-28$11.46/sh+3,475→ 31,191 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2016-05-28−3,475→ 0 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Right to Buy Restricted Stock Unit (RSU)
2016-05-26+5,222→ 5,222 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Right to Buy Restricted Stock Unit (RSU)
2016-05-25+5,282→ 5,282 total
Tax Payment
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2015-10-21$6.72/sh+10,000→ 27,716 total
Exercise of In-Money
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Non Qualified Stock Option (Right to Buy)
2015-10-21$6.72/sh−10,000→ 0 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2015-05-29$14.29/sh+4,219→ 17,716 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Units
2015-05-29−4,219→ 0 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Right to Buy Restricted Stock Unit (RSU)
2015-05-28+3,475→ 3,475 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit (RSU)
2013-06-07+3,496→ 3,496 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2013-05-16+1,667→ 10,001 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Units
2013-05-16−1,667→ 0 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2012-05-23+1,667→ 8,334 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Units
2012-05-23−1,667→ 0 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit (RSU)
2012-05-16+1,667→ 1,667 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Stock Option (Right to Buy)
2012-05-16$6.66/sh+5,000→ 30,000 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2011-12-11$5.64/sh+3,333→ 6,667 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Units
2011-12-11−3,333→ 0 total
Award
ACCELRYS, INC.
Common stock
2011-08-03+6,000→ 6,000 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2011-05-26+1,667→ 1,667 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Units
2011-05-26−1,667→ 0 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit (RSU)
2011-05-23+1,667→ 1,667 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Stock Option (Right to Buy)
2011-05-23$5.77/sh+5,000→ 25,000 total
Award
ACCELRYS, INC.
Restricted stock units
2010-08-03+18,000→ 18,000 total
Award
ACCELRYS, INC.
Common Stock
2010-07-01+48,641→ 48,641 total
Award
ACCELRYS, INC.
Incentive Stock Option (right to buy)
2010-07-01+3,872→ 3,872 total
Award
ACCELRYS, INC.
Non-Qualified Stock Option (right to buy)
2010-07-01+39,010→ 39,010 total
Award
ACCELRYS, INC.
Non-Qualified Stock Option (right to buy)
2010-07-01+39,010→ 39,010 total
Award
ACCELRYS, INC.
Non-Qualified Stock Option (right to buy)
2010-07-01+9,752→ 9,752 total
Award
ACCELRYS, INC.
Incentive Stock Option (right to buy)
2010-07-01+7,571→ 7,571 total

Companies

Recent Filings

Address

3340 HILLVIEW AVENUE C/O VENROCK

PALO ALTO, CA, 94304

View on SEC.gov